MedTrace Logo

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

NCT07131956 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-18

No results posted yet for this study

Summary

Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.

Conditions

  • Prostate Cancer (Diagnosis)
  • Prostate Cancer Patients Who Have Brachytherapy Seed Implant
  • Prostate Cancer Patients Treated by Radiotherapy
  • Prostate Cancer Recurrent

Sponsors & Collaborators

  • Bavarian Cancer Research Center (BZKF)

    collaborator UNKNOWN

  • University Hospital Augsburg

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Claudia Schweizer, MD · Strahlenklinik Universitätsklinikum Erlangen

  • Anna-Jasmina Donaubauer, Dr. rer. nat. · Strahlenklinik Universitätsklinikum Erlangen

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2028-07-31
Completion
2028-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07131956 on ClinicalTrials.gov